ZEPP
Zepp Health CorpPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Apr 24 Zepp Health Corp reported strong 2025 financial performance with 41.…
- R Jun 9 Zepp Health reported Q1 2026 revenue of $51.5M (+33.8% YoY), in line…
- S Jun 26 1 insider sell $45.3K at $4.61
- R Sep 2 Zepp Health reported Q2 2026 revenue of $63.5M (+6.9% YoY) but net l…
- R Sep 2 Zepp Health reported Q2 2026 revenue of $63.5M (+6.9% YoY) but GAAP…
- S Sep 23 to Sep 24 2 days of insider sells: $42.1K by 1 insider, avg $4.21
Signal stack
Where each data set points today.
- InsidersBEARISH
2 insiders sold $87.5K.
- InstitutionsMIXED
Q2 2026: 4 added (0 new), 3 trimmed or exited.
- TrendDOWNTREND
40% below its 50-day average. New closing low $2.54 on Oct 26.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | TRIM | $117.6K |
| Mitsubishi UFJ Asset Management Co., Ltd. | TRIM | $32.3K |
| GROUP ONE TRADING LLC | DOUBLED | $18.7K |
| RHUMBLINE ADVISERS | DOUBLED | $10.2K |
| SIMPLEX TRADING, LLC | NEAR_EXIT | $6.3K |
| OSAIC HOLDINGS, INC. | ADD | $2.6K |
| WELLS FARGO & COMPANY/MN | ADD | $683.00 |
| GOLDMAN SACHS GROUP INC | DOUBLED | $1.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Price is below the lowest target. Median implies +1627%.Targets as of Oct 27, 2026.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 24, 2026 | Yu Pengtao Chief Industrial Designer | SELL | $17.4K |
| Sep 23, 2026 | Yu Pengtao Chief Industrial Designer | SELL | $24.7K |
| Jun 26, 2026 | Deng Cheng Chief Financial Officer | EXERCISE | 22,875 sh |
| Jun 26, 2026 | Deng Cheng Chief Financial Officer | SELL | $45.3K |
| Jun 26, 2026 | Deng Cheng Chief Financial Officer | EXERCISE | 366,000 sh |
| Jun 26, 2026 | FAN Meihui Chief Technology Officer | EXERCISE | 520,000 sh |
| Jun 26, 2026 | FAN Meihui Chief Technology Officer | EXERCISE | 160,000 sh |
| Jun 26, 2026 | FAN Meihui Chief Technology Officer | EXERCISE | 200,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
5 filings · 1 bullish · 3 bearish · 1 neutral- BEARISH 6-KSep 2, 2026
Zepp Health reported Q2 2026 revenue of $63.5M (+6.9% YoY) but net loss widened to $11.3M from…
The widening losses and weak Q3 guidance suggest the growth story is stalling. Traders should watch Q3 2026 results for revenue and margin trends, and monitor whether supply constraints ease as…
- BEARISH PRESS-RELEASESep 1, 2026
Zepp Health reported Q2 2026 revenue of $63.5M (+6.9% YoY) but GAAP net loss widened to $11.3M…
The Q3 guidance midpoint implies a ~7% YoY revenue decline, a negative signal for a company that just returned to growth. Monitor Q3 actuals for supply recovery on Helio Strap and Bip; the widening…
- NEUTRAL INST-CLUSTERJun 11, 2026
Three mega-passive institutional investors (UBS, Morgan Stanley, BofA) dramatically increased…
The buying is entirely passive/index-driven, likely reflecting index reconstitution or a corporate event (e.g., share consolidation, delisting risk adjustment). Active managers are absent. Monitor…
- BEARISH 6-KJun 9, 2026
Zepp Health reported Q1 2026 revenue of $51.5M (+33.8% YoY), in line with guidance, with gross…
The sharp Q2 guidance deceleration (6-14% vs 33.8% in Q1) combined with persistent losses and rising short-term debt signals deteriorating fundamentals. Monitor the Q2 earnings report for actual…
All ZEPP filing & press-release reports (5)
- 6-K reportSep 2, 2026
- PRESS-RELEASE reportSep 1, 2026
- INST-CLUSTER reportJun 11, 2026
- 6-K reportJun 9, 2026
- 20-F reportApr 24, 2026